Company / SG&A per Share
Kura Oncology, Inc. SG&A per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.53
FY2025
5-year range
$0.69 / $1.53
FY2021-FY2025
Trend
+47.9%
vs FY2024
Sector context
#95 of 210
Health Care
What the data says
At $1.53, Kura Oncology, Inc.'s sg&a per share ranks #116 of 210 in the Health Care sector. Increased from $0.69 to $1.53 over the past 2 years.
Based on SEC 10-K filings.
1.53 in FY2025 with a 5-year CAGR of +20.9%.
Increased from $0.69 to $1.53 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +29.7%
- 5-Year CAGR
- +20.9%
- 10-Year CAGR
- -
Sector benchmark
#116 of 210 in Health CareTop 55% of 210This company $1.53 Sector average $40.75
▼
-96.2% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 47.9% year-over-year.
- Ranks #95 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.53 | +47.9% |
| FY2024 | $1.04 | +50.2% |
| FY2023 | $0.69 | -1.7% |
| FY2022 | $0.70 | +0.1% |
| FY2021 | $0.70 | +18.2% |
| FY2020 | $0.59 | +26.7% |
| FY2019 | $0.47 | +2.4% |
| FY2018 | $0.46 | +10.1% |
| FY2017 | $0.42 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026